Inhibition of lens epithelial cell adhesion by the calcium antagonist Mibefradil correlates with impaired integrin distribution and organization of the cytoskeleton
R. Beck et al., Inhibition of lens epithelial cell adhesion by the calcium antagonist Mibefradil correlates with impaired integrin distribution and organization of the cytoskeleton, GR ARCH CL, 239(6), 2001, pp. 452-458
Citations number
26
Categorie Soggetti
Optalmology
Journal title
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
Background: Posterior capsule opacification is the most common complication
of primary cataract surgery and is caused by migration and proliferation o
f residual lens epithelial cells onto the posterior capsule. Interfering wi
th the mechanisms involved in cell adhesion is a suitable approach to preve
nt posterior capsule opacification. Methods: Mibefradil, a T-type calcium-c
hannel blocker, was used to examine the influence on adhesion-mediating mec
hanisms in human lens epithelial cells derived from cataract surgery. Adhes
ion was evaluated by light microscopy on the anteri- or capsules. Expressio
n of integrin receptors was studied by flow cytometry. The influence on the
distribution of integrin receptors on the cell surface and the organizatio
n of the cytoskeleton was examined by immunofluorescence using a confocal m
icroscope. Results: The calcium-channel blocker Mibefradil inhibited cell a
dhesion on the anterior capsule wall at concentrations between 10 and 100 m
uM. The cells expressed the integrin subunits beta1 and alpha3. Mibefradil
distinctly impaired the distribution of these integrins on the cell surface
in culture. The cells express the cytoskeletal components actin, vimentin
and, very weakly, cytokeratin. The structural organization of the actin fil
aments and vimentin was strongly disrupted with pronounced fragmentation of
the actin filaments in the presence of the calcium-channel blocker. Conclu
sion: The results suggest that the inhibition of cell adhesion by the calci
um-channel blocker Mibefradil involves the impairment of integrin-mediated
mechanisms. The use of this calcium antagonist appears to be a suitable the
rapeutic approach to prevent posterior capsule opacification.